Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer

Cong Zeng, View ORCID ProfileJohn P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No Joon Song, Mark P. Rubinstein, Peter G. Shields, Zihai Li, View ORCID ProfileShan-Lu Liu
doi: https://doi.org/10.1101/2021.12.28.21268398
Cong Zeng
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Evans
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
3Molecular, Cellular and Developmental Biology Program, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John P. Evans
Karthik Chakravarthy
4Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Panke Qu
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Reisinger
5Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
No Joon Song
4Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark P. Rubinstein
4Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Shields
5Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Liu.6244{at}osu.edu Zihai.Li{at}osumc.edu Peter.Shields{at}osumc.edu
Zihai Li
4Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Liu.6244{at}osu.edu Zihai.Li{at}osumc.edu Peter.Shields{at}osumc.edu
Shan-Lu Liu
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
6Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA
7Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shan-Lu Liu
  • For correspondence: Liu.6244{at}osu.edu Zihai.Li{at}osumc.edu Peter.Shields{at}osumc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: December 2021 to July 2025

AbstractFullPdf
Dec 20214720109
Jan 2022143944271
Feb 2022147739
Mar 2022136524
Apr 202294127
May 202257214
Jun 202278210
Jul 20225768
Aug 20224435
Sep 20224349
Oct 20223435
Nov 20222427
Dec 20223114
Jan 20232919
Feb 20232612
Mar 20232320
Apr 20231813
May 20231816
Jun 20231044
Jul 2023632
Aug 202319134
Sep 202321101
Oct 2023750
Nov 202375103
Dec 20231116
Jan 20241023
Feb 20241613
Mar 2024802
Apr 20241345
May 20241111
Jun 20241022
Jul 2024726
Aug 20241430
Sep 20241215
Oct 20241060
Nov 2024837
Dec 20241116
Jan 20252225
Feb 2025774
Mar 2025181111
Apr 202520108
May 202521157
Jun 2025391913
Jul 2025001
Back to top
PreviousNext
Posted December 30, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer
Cong Zeng, John P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No Joon Song, Mark P. Rubinstein, Peter G. Shields, Zihai Li, Shan-Lu Liu
medRxiv 2021.12.28.21268398; doi: https://doi.org/10.1101/2021.12.28.21268398
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer
Cong Zeng, John P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No Joon Song, Mark P. Rubinstein, Peter G. Shields, Zihai Li, Shan-Lu Liu
medRxiv 2021.12.28.21268398; doi: https://doi.org/10.1101/2021.12.28.21268398

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)